NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Stock Market Update

Market Performance

On March 16, the BSE Sensex surged by 938.93 points or 1.26% to close at 75,502.85, while the Nifty 50 rose by 257.70 points or 1.11% to finish at 23,408.80. This recovery indicates that investors are seizing opportunities to buy certain large-cap stocks following a significant drop.

Market Analysis

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Analysts suggest that the markets began the week with volatility and gained over a percentage, breaking their recent downward trend, aided by opportunistic buying. The recovery primarily indicates that investors are seizing the opportunity to buy certain large-cap stocks following the significant drop.

Global Cues

According to Hariprasad K, SEBI-registered Research Analyst and Founder, Livelong Wealth, Indian equities are expected to open on a positive note today, supported by firm global cues. Global sentiment improved overnight as easing crude oil prices supported risk appetite. The Dow Jones Industrial Average closed nearly 400 points higher, snapping a three-week losing streak as crude oil retreated below the $95 per barrel mark.

Stock Recommendations

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Based on the analysis, the following stocks are recommended for purchase:

Jindal SAW Ltd

  • Buy above ₹199
  • Stop loss: ₹187
  • Target price: ₹223 (multiday)
  • Key metrics: P/E: 10.99, 52-week high: ₹286.40, Volume: 25.19M
  • Technical analysis: Support at ₹175, resistance at ₹225
  • Risk factors: High debt levels, commodity price volatility, and declining profitability

State Bank of India

  • Buy above ₹1,070
  • Stop loss: ₹1,020
  • Target price: ₹1,165 (multiday)
  • Key metrics: P/E: 12.47, 52-week high: ₹1,234.70, Volume: 15.32M
  • Technical analysis: Support at ₹1,150, resistance at ₹1,320
  • Risk factors: High exposure to volatile sectors, regulatory changes, and economic sensitivity

Astral Ltd

  • Buy above ₹1,625
  • Stop loss: ₹1,510
  • Target price: ₹1,785 (multiday)
  • Key metrics: P/E: Not available, 52-week high: Not available, Volume: Not available
  • Technical analysis: Support at ₹1,500, resistance at ₹1,800
  • Risk factors: Not available

Adani Power Ltd

  • Buy above ₹1,500
  • Stop loss: ₹1,400
  • Target price: ₹1,650 (multiday)
  • Key metrics: P/E: Not available, 52-week high: Not available, Volume: Not available
  • Technical analysis: Support at ₹1,450, resistance at ₹1,700
  • Risk factors: Not available

BSE Ltd

  • Buy above ₹1,500
  • Stop loss: ₹1,400
  • Target price: ₹1,650 (multiday)
  • Key metrics: P/E: Not available, 52-week high: Not available, Volume: Not available
  • Technical analysis: Support at ₹1,450, resistance at ₹1,700
  • Risk factors: Not available

Investor Takeaway

Investors may consider buying large-cap stocks following the market's recovery.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.